| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $48.95K | $63.33K | $120.53K | $182.17K | $839.45K |
| R&D | – | – | – | – | – |
| SG&A | $23.11K | $34.32K | $27.56K | $26.57K | $32.28K |
| Operating Income | -$48.95K | -$63.33K | -$120.53K | -$182.17K | -$839.45K |
| Interest Expense | – | – | – | $1.00K | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$56.18K | -$68.34K | -$125.53K | -$130.17K | -$830.06K |
| EPS (basic) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | -0.0100 |
| EPS (diluted) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | -0.0100 |
| Shares (diluted) | $83.55M | $83.55M | $81.67M | $79.95M | $73.37M |